SCHEMBL3392155

SCHEMBL3392155

OC(Nc1ccc(Br)cn1)c1c(-c2ccc(F)c(F)c2)nc2ccc(Br)cn12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 1/20 0.39
PRNP P04156 4/20 0.35
FDPS P14324 1/20 0.34
TP53 P04637 2/20 0.33
MAPT P10636 2/20 0.33
MEN1 O00255 1/20 0.33
HPGD P15428 1/20 0.33
ALOX15 P16050 1/20 0.33
PPARG P37231 1/20 0.33
KMT2A Q03164 1/20 0.33
NCOA2 Q15596 1/20 0.33
NCOA1 Q15788 1/20 0.33
NCOA3 Q9Y6Q9 1/20 0.33
GAA P10253 2/20 0.33
ALOX5 P09917 1/20 0.33
TGFBR1 P36897 2/20 0.33
TGFBR2 P37173 1/20 0.33
MAPK14 Q16539 1/20 0.32
PIK3CA P42336 1/20 0.31
MTOR P42345 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3360465 0.91 TRPA1 (0.41) TRPA1PRNPTP53MAPTMEN1
SCHEMBL3395127 0.89 AHR (0.37) TRPA1PRNPFDPSTP53MAPT
SCHEMBL14632043 0.83 FDPS (0.33) TRPA1PRNPFDPSTP53MAPT
SCHEMBL15879713 0.81 SLC2A1 (0.46) TRPA1PRNPTP53MAPTGAA
SCHEMBL3360406 0.79 MEN1 (0.41) TRPA1FDPSTP53MAPTMEN1
SCHEMBL3359454 0.78 NR1H4 (0.39) TRPA1TP53MAPTMEN1KMT2A
SCHEMBL14632083 0.74 GABRD (0.38) TP53MAPTMEN1KMT2AGAA
SCHEMBL3391218 0.73 MAPT (0.45) TRPA1FDPSTP53MAPTMEN1
SCHEMBL3393907 0.72 TP53 (0.45) TP53MAPTHPGDGAATGFBR1
SCHEMBL1691416 0.70 PRNP (0.50) TRPA1PRNPAHRSLC2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150239905-A1 IMIDAZOPYRIDINE COMPOUNDS BIOVITRUM AB (PUBL) (SE) 2015-08-27 US disclosed
US-20140206662-A1 Imidazopyridine Compounds PROXIMAGEN LTD. (GB) 2014-07-24 US disclosed
EP-2376490-B1 IMIDAZOPYRIDINE COMPOUNDS PROXIMAGEN LTD (GB) 2013-01-23 EP disclosed
WO-2010064020-A1 IMIDAZOPYRIDINE COMPOUNDS PROXIMAGEN LTD. (GB) 2010-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150239905-A1 IMIDAZOPYRIDINE COMPOUNDS SSB, MIF, IDO1 TRPA1 162/4885PRNP 1606/4885FDPS 376/4885
US-20140206662-A1 Imidazopyridine Compounds SSB, NFKBIA, TPMT TRPA1 159/4885PRNP 1527/4885FDPS 373/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.